| Metastasis and immune evasion from extracellular cGAMP hydrolysis J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ... Cancer discovery 11 (5), 1212-1227, 2021 | 167 | 2021 |
| Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells L Gerosa, C Chidley, F Fröhlich, G Sanchez, SK Lim, J Muhlich, JY Chen, ... Cell systems 11 (5), 478-494. e9, 2020 | 87 | 2020 |
| A graph-based recovery and decomposition of Swanson’s hypothesis using semantic predications D Cameron, O Bodenreider, H Yalamanchili, T Danh, S Vallabhaneni, ... Journal of biomedical informatics 46 (2), 238-251, 2013 | 80 | 2013 |
| Significance of ER–Src axis in hormonal therapy resistance S Vallabhaneni, BC Nair, V Cortez, R Challa, D Chakravarty, RR Tekmal, ... Breast cancer research and treatment 130, 377-385, 2011 | 79 | 2011 |
| Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells BC Nair, S Vallabhaneni, RR Tekmal, RK Vadlamudi Breast cancer research 13, 1-11, 2011 | 67 | 2011 |
| ERK3 promotes endothelial cell functions by upregulating SRC‐3/SP1‐mediated VEGFR2 expression W Wang, K Bian, S Vallabhaneni, B Zhang, RC Wu, BW O'Malley, W Long Journal of cellular physiology 229 (10), 1529-1537, 2014 | 47 | 2014 |
| Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity JC Melms, S Vallabhaneni, CE Mills, C Yapp, JY Chen, E Morelli, ... Cancer research 80 (4), 798-810, 2020 | 25 | 2020 |
| Synthesis and their possible biological activities of few formazans of 3-amino-2-sulphanyl-2, 3, 4, 5, 6, 7, 8-hexahydro (1) benzothieno (2, 3-d) pyrimidin-4 (1H)-one N Lakshmi, V Haritha, V Sreeram, D Rajalakshmi, N Sindhura, ... Rayasan J Chem 2 (1), 71-74, 2009 | 13 | 2009 |
| Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy TSC Ng, H Hu, S Kronister, C Lee, R Li, L Gerosa, SA Stopka, ... Science Advances 8 (17), eabl6339, 2022 | 8 | 2022 |
| Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice S Vallabhaneni, J Liu, M Morel, J Wang, FJ DeMayo, W Long Molecular Oncology 16 (5), 1184-1199, 2022 | 5 | 2022 |
| Abstract B132: Inhibition of Haspin kinase to promote cell-intrinsic and extrinsic anticancer therapy JC Melms, S Vallabhaneni, CE Mills, K Wucherpfennig, PK Sorger, B Izar Molecular Cancer Therapeutics 18 (12_Supplement), B132-B132, 2019 | | 2019 |
| A highly selective dual Haspin-kinase and PIM-inhibitor overcomes RAF/MEK-inhibitor resistance in melanoma JC Melms, S Vallabhaneni, CE Mills, PK Sorger, K Wucherpfennig, B Izar Cancer Research 79 (13_Supplement), 2068-2068, 2019 | | 2019 |
| Conditional ERK3 overexpression and PTEN deletion induce lung tumors in mice S Vallabhaneni, M Morel, MJ Tsai, FJ Demayo, W Long Cancer Research 78 (13_Supplement), 5098-5098, 2018 | | 2018 |
| Abstract P5-06-12: Roscovitine Confers Tumor Suppressive Effect on Therapy-Resistant Breast Tumor Cells BC Nair, S Vallabhaneni, R Li, RR Tekmal, RK Vadlamudi Cancer Research 70 (24_Supplement), P5-06-12-P5-06-12, 2010 | | 2010 |
| Abstract P4-02-10: Significance of ER-Coregulator-Src Axis in Hormonal Resistance S Vallabhaneni, BC Nair, V Cortez, D Chakravarty, R Challa, RR Tekmal, ... Cancer Research 70 (24_Supplement), P4-02-10-P4-02-10, 2010 | | 2010 |
| Roscovitine modulates ERα/ERβ ratio: A novel means to target hormonal therapy resistance BC Nair, M Morales, HBB Nair, S Vallabhaneni, R Li, RR Tekmal, ... Cancer Research 70 (8_Supplement), 4604-4604, 2010 | | 2010 |
